New cases: pulmonary smear-negative in Marshall Islands
Marshall Islands: New cases: pulmonary smear-negative was 39 in 2012. ◆ Volatile
Latest (2012)
39
Change on year
up 95.0%
World rank
155th
of 192 countries
All-time high
97
in 2007
All-time low
11
in 1998
Years of data
16
1996–2012
New cases: pulmonary smear-negative in Marshall Islands, 1996–2012
Source: World Health Organization, Global Health Observatory.
Analysis
In 2012, new cases: pulmonary smear-negative in Marshall Islands stood at 39.
That represents a change of up 95.0% on the previous year and up 116.7% over ten years.
Over the whole period, new cases: pulmonary smear-negative in Marshall Islands peaked at 97 in 2007 and was at its lowest, 11, in 1998.
Marshall Islands ranks 155th of 192 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
New cases: pulmonary smear-negative in Marshall Islands, year by year
| Year | Value | Change |
|---|---|---|
| 1996 | 19 | — |
| 1998 | 11 | -42.1% |
| 1999 | 19 | +72.7% |
| 2000 | 17 | -10.5% |
| 2001 | 23 | +35.3% |
| 2002 | 18 | -21.7% |
| 2003 | 22 | +22.2% |
| 2004 | 36 | +63.6% |
| 2005 | 31 | -13.9% |
| 2006 | 43 | +38.7% |
| 2007 | 97 | +125.6% |
| 2008 | 62 | -36.1% |
| 2009 | 55 | -11.3% |
| 2010 | 50 | -9.1% |
| 2011 | 20 | -60.0% |
| 2012 | 39 | +95.0% |
Marshall Islands compared with similar countries
- Marshall Islands's 39 is below the median for upper middle income countries, which is 617, 6% of the median. (57 countries reporting)
- Marshall Islands's 39 is below the median for East Asia & Pacific, which is 550.5, 7% of the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 16.33 | 11 | 19 | 3 |
| 2000s | 40.4 | 17 | 97 | 10 |
| 2010s | 36.33 | 20 | 50 | 3 |
Countries ranked near Marshall Islands
- 153 Slovenia 49 compare
- 154 Bahrain 47 compare
- 155 Oman 39 compare
- 157 Sao Tome and Principe 34 compare
- 158 Montenegro 33 compare
More health data for Marshall Islands
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 3.09 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,179 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -7.92 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0494 units per person (2025)
- Population ages 00-04, male, annual growth rate -8.43 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is new cases: pulmonary smear-negative in Marshall Islands?
- New cases: pulmonary smear-negative in Marshall Islands was 39 in 2012, according to World Health Organization, Global Health Observatory.
- What is the highest new cases: pulmonary smear-negative recorded in Marshall Islands?
- The highest recorded value was 97 in 2007.
- What is the lowest new cases: pulmonary smear-negative recorded in Marshall Islands?
- The lowest recorded value was 11 in 1998.
- How does Marshall Islands rank for new cases: pulmonary smear-negative?
- Marshall Islands ranks 155th out of 192 countries with data for 2012.
- Is new cases: pulmonary smear-negative rising or falling in Marshall Islands?
- Over the last ten years it is up 116.7%. The long-run trend across the full record is volatile.
- Where does this Marshall Islands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New cases: pulmonary smear-negative. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).